Novel Method for Probe Labeling

Information

  • Research Project
  • 6736441
  • ApplicationId
    6736441
  • Core Project Number
    R43GM070030
  • Full Project Number
    1R43GM070030-01
  • Serial Number
    70030
  • FOA Number
  • Sub Project Id
  • Project Start Date
    6/1/2004 - 20 years ago
  • Project End Date
    1/31/2005 - 19 years ago
  • Program Officer Name
    DASCHNER, PHILLIP J.
  • Budget Start Date
    6/1/2004 - 20 years ago
  • Budget End Date
    1/31/2005 - 19 years ago
  • Fiscal Year
    2004
  • Support Year
    1
  • Suffix
  • Award Notice Date
    4/13/2004 - 20 years ago
Organizations

Novel Method for Probe Labeling

[unreadable] DESCRIPTION (provided by applicant): This Small Business Innovation Research Phase I project aims to develop a novel probe labeling method to increase the sensitivity of in situ hybridization assays. Although this probe labeling method can be used for a variety of RNA and DNA assay formats, this proposal will focus ondeveloping the technology for use with viral assays, where there is an urgent need for signal amplification technologies. Current methods for detecting viral infected cells include in situ PCR and fluorescence in situ hybridization. In situ PCR, however, is prone to several artifacts, such as non-specific target amplification and amplicon leakage out of the cell. Signal amplification methods, such as tyramide signal amplification (TSA), have increased the sensitivity of in situ hybridization assays, however, use of TSA increases assay complexity by adding several procedural steps. Oligonucleotide probes modified by enzymatic "tailing" increase the sensitivity of in situ hybridization assays, however, this modification complicates labeling procedures and increases production costs. Furthermore, use of these probes is limited due to licensing issues. This proposal will combine a novel probe labeling method with image scanning cytometry to develop sensitive in situ hybridization assays for detecting rare viral infected cells. [unreadable] [unreadable] [unreadable] [unreadable]

IC Name
NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES
  • Activity
    R43
  • Administering IC
    GM
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    125326
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    821
  • Ed Inst. Type
  • Funding ICs
    NIGMS:125326\
  • Funding Mechanism
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    ONE CELL SYSTEMS, INC
  • Organization Department
  • Organization DUNS
  • Organization City
    CAMBRIDGE
  • Organization State
    MA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    02139
  • Organization District
    UNITED STATES